Establishment and genomic characterization of the new chordoma cell line Chor-IN-1Roberta Bosotti, Antonella Isacchi, Laura Raddrizzani et al.|Scientific Reports|2017Cited by 17
Optimization of Diarylthiazole B‐Raf Inhibitors: Identification of a Compound Endowed with High Oral Antitumor Activity, Mitigated hERG Inhibition, and Low Paradoxical EffectMaurizio Pulici, Marina Ciomei, Gabriella Traquandi et al.|ChemMedChem|2014Cited by 9
Abstract 4539: NMS-P862, a novel orally available selective small molecule Cdc7 inhibitor with antitumor efficacy in breast cancerAlessia Montagnoli, Arturo Galvani, Maria Menichincheri et al.|Cancer Research|2014Cited by 0
Abstract 2522: Identification and characterization of new highly selective and potent BRAF inhibitorsMaurizio Pulici, Marina Ciomei, Nadia Amboldi et al.|Cancer Research|2010Cited by 0
Abstract 3754: Characterization of NMS-P285, a new highly selective and potent BRAF inhibitorMaurizio Pulici, Marina Ciomei, Nadia Amboldi et al.|Cancer Research|2012Cited by 0